A clinical and economic analysis of the use of dapagliflozin in patients with chronic heart failure in the entire spectrum of left ventricular ejection fraction in the Russian Federation
Aim. To estimate the cost-effectiveness of dapagliflozin across the range of ejection fraction in patients with heart failure (HF) in Russian Federation. Materials and methods. Cost-effectiveness model was developed for estimate the use of dapagliflozin as part of standard therapy in patients wit...
| Autors principals: | , , , , , , |
|---|---|
| Format: | Article |
| Idioma: | Russian |
| Publicat: |
"Consilium Medicum" Publishing house
2023-11-01
|
| Col·lecció: | Терапевтический архив |
| Matèries: | |
| Accés en línia: | https://ter-arkhiv.ru/0040-3660/article/viewFile/622974/138794 |